Veronica Delgadillo
Overview
Explore the profile of Veronica Delgadillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olive-Cirera G, Fonseca E, Chen L, Fetta A, Martinez-Hernandez E, Guasp M, et al.
Lancet Neurol
. 2024 Dec;
24(1):54-64.
PMID: 39706634
Background: The usefulness of current diagnostic approaches in children with suspected autoimmune encephalitis is unknown. We aimed to assess the diagnosis of autoimmune encephalitis in clinical practice and to compare...
2.
Fonseca E, Olive-Cirera G, Martinez-Hernandez E, Guasp M, Naranjo L, Ruiz-Garcia R, et al.
Neurology
. 2024 Aug;
103(6):e209682.
PMID: 39190859
Background And Objectives: The 2023 criteria for myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) perform well in adults but have not been assessed in children. Methods: This prospective observational nationwide study...
3.
Aguilera C, Gabau E, Ramirez-Mallafre A, Brun-Gasca C, Dominguez-Carral J, Delgadillo V, et al.
PLoS One
. 2021 Oct;
16(10):e0258766.
PMID: 34653234
Angelman syndrome (AS) is a neurogenetic disorder characterized by severe developmental delay with absence of speech, happy disposition, frequent laughter, hyperactivity, stereotypies, ataxia and seizures with specific EEG abnormalities. There...
4.
Montero R, Yubero D, Salgado M, Gonzalez M, Campistol J, Del Mar OCallaghan M, et al.
Sci Rep
. 2019 Jan;
9(1):793.
PMID: 30692599
Identifying diseases displaying chronic low plasma Coenzyme Q (CoQ) values may be important to prevent possible cardiovascular dysfunction. The aim of this study was to retrospectively evaluate plasma CoQ concentrations...
5.
Aguilera C, Gabau E, Laurie S, Baena N, Derdak S, Capdevila N, et al.
Mol Genet Genomic Med
. 2018 Dec;
7(1):e00511.
PMID: 30548424
Background: Patients affected by Angelman syndrome (AS) present severe intellectual disability, lack of speech, ataxia, seizures, abnormal electroencephalography (EEG), and a characteristic behavioral phenotype. Around 10% of patients with a...
6.
Yubero D, Montero R, OCallaghan M, Pineda M, Meavilla S, Delgadillo V, et al.
JIMD Rep
. 2015 Jul;
25:1-7.
PMID: 26205433
Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by deficiencies of lysosomal enzymes catalyzing degradation of glycosaminoglycans (GAGs). Previously, we reported a secondary plasma coenzyme Q (CoQ) deficiency...
7.
Delgadillo V, Del Mar OCallaghan M, Gort L, Coll M, Pineda M
Orphanet J Rare Dis
. 2013 Dec;
8:189.
PMID: 24314109
Background: Mucopolysaccharidosis type III (MPS III), or Sanfilippo syndrome, is caused by a deficiency in one of the four enzymes involved in the lysosomal degradation of heparan sulphate. Four MPS...
8.
Delgadillo V, Del Mar OCallaghan M, Artuch R, Montero R, Pineda M
J Inherit Metab Dis
. 2011 May;
34(5):1039-44.
PMID: 21556833
Background: Mucopolysaccharidosis type III (Sanfilippo syndrome) is a group of autosomal recessive disorders caused by a deficiency in one of the four enzymes involved in the lysosomal degradation of heparan...